It has been reported that the SMAD4 gene is deleted or mutated in over half of pancreatic ductal adenocarcinomas.32,33 Whether therapeutic responses differ depending on SMAD4 alterations at baseline warrants further investigation. Here, SMAD4 is linked to pancreatic ductal adenocarcinoma.